National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	L.L
L01XG03	NINLARO	B	Ixazomib - 2.3mg	2.3mg	Capsule, hard	272,619,919 L.L
C09AA05	NORMOPRIL	G	Ramipril - 2.5mg	2.5mg	Tablet	229,797 L.L
J05AG01	NEPINE	G	Nevirapine - 200mg	200mg	Tablet	5,921,678 L.L
A07AA11	NORMIX TAB	B	Rifaximin alpha - 200mg	200mg	Tablet, film coated	827,807 L.L
A07AX03	NIFUNAL	G	Nifuroxazide - 200mg	200mg	Capsule, hard	217,702 L.L
L01EA03	NILORA	G	Nilotinib - 200mg	200mg	Capsule, hard	122,185,399 L.L
C04AX21	NAFTILUX	B	Naftidrofuryl oxalate acid - 200mg	200mg	Capsule	533,505 L.L
C04AX21	NAFTIPRAX	B	Naftidrofuryl hydrogen oxalate - 200mg	200mg	Tablet, film coated	614,328 L.L
L01EX02	NEXAVAR	B	Sorafenib - 200mg	200mg	Tablet, film coated	86,139,938 L.L
M01AH01	NORMOCOXIB	G	Celecoxib - 200mg	200mg	Capsule, hard	798,242 L.L
L01EX02	NEXAVAR	B	Sorafenib - 200mg	200mg	Tablet, film coated	L.L
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 200units	200units	Injectable lyophilised powder for solution	25,175,058 L.L
A02BC01	NEOOPRAZOLE	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	407,184 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 20mg	20mg	Tablet, gastroresistant	1,005,194 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 20mg	20mg	Tablet, gastroresistant	1,005,194 L.L
A02BC05	NEXPRAZOL 20	G	Esomeprazole - 20mg	20mg	Tablet, enteric coated	275,168 L.L
N06AB03	NEANXETIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	422,351 L.L
C08CA05	NIFELAT R	G	Nifedipine - 20mg	20mg	Tablet, sustained release	388,370 L.L
L01CA04	NAVELBINE	B	Vinorelbine (ditartrate) - 20mg	20mg	Capsule, soft gelatin	4,048,997 L.L
C01DX16	NICORANDIL BIOGARAN	G	Nicorandil - 20mg	20mg	Tablet	822,432 L.L
C01DX16	NICORANDIL BIOGARAN	G	Nicorandil - 20mg	20mg	Tablet	822,432 L.L
M03AC11	NIMBEX	B	Cisatracurium (besylate) - 20mg/10ml	20mg/10ml	Injectable solution	2,010,388 L.L
M03AC11	NIMBEX	B	Cisatracurium (besylate) - 20mg/10ml	20mg/10ml	Injectable solution	2,010,388 L.L
N02BG06	NEO-PAN	G	Nefopam HCl - 20mg/2ml	20mg/2ml	Injectable solution	483,783 L.L
N02AF02	NALBUPHINE RENAUDIN 1%	G	Nalbuphine HCl - 20mg/2ml	20mg/2ml	Injectable solution	1,181,238 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	67,369,332 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	L.L
N02BF02	NEUREXAL	G	Pregabalin - 25mg	25mg	Capsule	321,754 L.L
M01AE17	NORMODEX	G	Dexketoprofen - 25mg	25mg	Tablet, film coated	279,519 L.L